Latest News

  • Alkermes Announces the Appointment of Richard Gaynor, M.D. and Andy Wilson to its Board of Directors and the Retirement of Director Floyd Bloom, M.D. Read More
  • Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis Read More
  • Alkermes Announces Settlement With Amneal Over VIVITROL® Patent Dispute Read More

Investors

Working at Alkermes